老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Evaxion Biotech A/S

5.29
+0.19003.73%
盘后：5.290.00000.00%18:43 EST
成交量：5.32万
成交额：27.97万
市值：4,392.13万
市盈率：-4.53
高：5.46
开：5.10
低：5.03
收：5.10
52周最高：12.15
52周最低：1.20
股本：830.27万
流通股本：553.19万
量比：0.86
换手率：0.96%
股息：- -
股息率：- -
每股收益(TTM):-1.1674
每股收益(LYR):-9.8491
净资产收益率：-64.99%
总资产收益率：-25.62%
市净率：2.65
市盈率(LYR):-0.54

数据加载中...

总览公司新闻资讯公告
2024/01/23

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/12

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2023/04/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/08/24

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/22

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/07/07

招股说明书

F-1 - Registration statement for certain foreign private issuers
2022/06/01

SEC问询函

CORRESP [Cover] - Correspondence
2022/03/31

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/10/29

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/29

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/26

招股说明书

F-1 - Registration statement for certain foreign private issuers
2021/05/13

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/04/07

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/04/06

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/06

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/02

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/02

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/01

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/02/01

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/25

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
更多